Research Topics
| A P BergerSummaryAffiliation: University of Innsbruck Country: Austria Publications
| Collaborators
|
Detail Information
Publications
Microsatellite alterations in human bladder cancer: detection of tumor cells in urine sediment and tumor tissueAndreas P Berger
Department of Urology, University of Innsbruck, Anichstrasse 35, A 6020 Innsbruck, Austria
Eur Urol 41:532-9. 2002..Loss of heterozygosity (LOH) studies have demonstrated that alterations in microsatellite regions are common in bladder cancer. This observation offers the possibility of early tumor detection by examining the DNA of urinary sediment...- Complication rate of transrectal ultrasound guided prostate biopsy: a comparison among 3 protocols with 6, 10 and 15 coresAndreas P Berger
Department of Urology and Pathology, University of Innsbruck, Innsbruck, Austria
J Urol 171:1478-80; discussion 1480-1. 2004..Moreover the impact of different biopsy protocols comprising varying numbers of biopsy cores on the complication rate was evaluated... - Safer transurethral resection of the prostate: coagulating intermittent cutting reduces hemostatic complicationsAndreas P Berger
Department of Urology, University of Innsbuck, Austria
J Urol 171:289-91. 2004..The impact of CIC on bleeding and blood transfusion rates as well as the occurrence of the TUR syndrome were investigated... - Single-agent chemotherapy with docetaxel significantly reduces PSA levels in patients with high-grade localized prostate cancersAndreas P Berger
Department of Urology, University of Innsbruck, Innsbruck, Austria
Urol Int 73:110-2. 2004..To date there are only few reports on chemotherapy for localized prostate cancer... - Early detection of prostate cancer with low PSA cut-off values leads to significant stage migration in radical prostatectomy specimensAndreas P Berger
Department of Urology, University of Innsbruck, Austria
Prostate 57:93-8. 2003.... - Longitudinal PSA changes in men with and without prostate cancer: assessment of prostate cancer riskAndreas P Berger
Department of Urology, University of Innsbruck, Innsbruck, Austria
Prostate 64:240-5. 2005..To determine longitudinal PSA changes over a period of 10 years in patients with and without prostate cancer... - Increased growth factor production in a human prostatic stromal cell culture model caused by hypoxiaAndreas P Berger
Department of Urology, University of Innsbruck, Austria
Prostate 57:57-65. 2003..Using a cell culture model of human prostatic stromal cells, we investigated the effects of hypoxia on activation of hypoxia-inducible factor 1 (HIF 1) and on the production of growth factors... - Vascular damage induced by type 2 diabetes mellitus as a risk factor for benign prostatic hyperplasiaA P Berger
Department of Urology, University of Innsbruck, Anichstrasse 35, 6020 Innsbruck, Austria
Diabetologia 48:784-9. 2005.... - Suprapubic electroresection of prostate in three patients with benign prostatic hyperplasia and previous surgery for long urethral strictureAndreas P Berger
Department of Urology, University of Innsbruck, Innsbruck, Austria
Urology 65:798. 2005..The good outcome demonstrated the feasibility and safety of prostate resection using a suprapubic approach, which may become a treatment option in this group of patients... - A comparison of one-stage procedures for post-traumatic urethral stricture repairAndreas P Berger
Department of Urology, University of Innsbruck, Innsbruck, Austria
BJU Int 95:1299-302. 2005..To compare the results and complication rates of various one-stage treatments for repairing a post-traumatic urethral stricture... - Relapse after radical prostatectomy correlates with preoperative PSA velocity and tumor volume: results from a screening populationAndreas P Berger
Department of Urology, Medical University of Innsbruck, Innsbruck, Austria
Urology 68:1067-71. 2006..Longitudinal PSA changes in men with prostate cancer have been reported to be significantly different from those without prostate cancer... - Atherosclerosis as a risk factor for benign prostatic hyperplasiaAndreas P Berger
Department of Urology, Medical University of Innsbruck, Austria
BJU Int 98:1038-42. 2006..To evaluate the relationship between clinical benign prostatic hyperplasia (BPH) and atherosclerosis, using colour Doppler ultrasonography (CDUS) and symptom scores... - Screening with low PSA cutoff values results in low rates of positive surgical margins in radical prostatectomy specimensAndreas P Berger
Department of Urology, University of Innsbruck, Innsbruck, Austria
Prostate 53:241-5. 2002..The aim of the present study was to determine the predictive value of preoperative serum prostate specific antigen (PSA) values for the rate of positive margins in radical retropubic prostatectomy... - Vascular resistance in the prostate evaluated by colour Doppler ultrasonography: is benign prostatic hyperplasia a vascular disease?Andreas P Berger
Department of Urology and Radiology, Medical University of Innsbruck, Austria
BJU Int 98:587-90. 2006.... - Management of neonates with large abdominal wall defects and undescended testisAndreas P Berger
Department of Pediatric Surgery, Medical University of Innsbruck, Innsbruck, Austria
Urology 68:175-8. 2006..Large abdominal and diaphragmatic defects are known to be associated with cryptorchidism, yet the reported incidence varies widely... - Transurethral microwave thermotherapy (TUMT) with the Targis System: a single-centre study on 78 patients with acute urinary retention and poor general healthAndreas P Berger
Department of Urology, University of Innsbruck, Anichstrasse 35, A 6020, Innsbruck, Austria
Eur Urol 43:176-80. 2003..To evaluate the Targis System in men presenting with acute urinary retention, high prostate volume and high operative risk... - Vascular damage as a risk factor for benign prostatic hyperplasia and erectile dysfunctionAndreas P Berger
Department of Urology, University of Innsbruck, Anichstrasse 35, A 6020 Innsbruck, Austria
BJU Int 96:1073-8. 2005.... - Characteristics of prostate cancers detected at low PSA levelsWolfgang Horninger
Department of Urology, University of Innsbruck, Austria
Prostate 58:232-7. 2004..However, concerns have been raised that screening with low PSA levels may detect clinically insignificant cancers... - Genetic aberrations in prostate carcinoma detected by comparative genomic hybridization and microsatellite analysis: association with progression and angiogenesisDagmar M Strohmeyer
Department of Urology, University of Innsbruck, Innsbruck, Austria
Prostate 59:43-58. 2004.... - [Ultrasound contrast agents and prostate cancer]F Frauscher
Klinik für Radiodiagnostik II, Medizinische Universitat Innsbruck
Radiologe 45:544-51. 2005..Introduction of ultrasound contrast agents ("echo signal enhancers") significantly increased the diagnostic potential of this method, making it possible to visualize tumor vascularization... - [The value of ultrasound (US) in the diagnosis of prostate cancer]F Frauscher
Abteilung für Radiodiagnostik II, Universitätsklinik für Radiodiagnostik Innsbruck, Austria
Radiologe 43:455-63. 2003..However, future clinical trials will be needed to determine the promise of contrast-enhanced US of the prostate evolves into clinical application... - Clinical and pathologic features of prostate cancer detected after repeat false-negative biopsy in a screening populationHannes Steiner
Department of Urology, University of Innsbruck, Innsbruck, Austria
Prostate 58:277-82. 2004..The present study was designed to investigate whether the clinical or pathologic features of prostate cancer (PCa) are related to the number of repeat biopsies required to establish the diagnosis of PCa... - Two cycles of cisplatin-based chemotherapy for low-volume retroperitoneal stage II nonseminomatous germ cell tumoursHannes Steiner
Department of Urology, University of Innsbruck, Austria
BJU Int 98:349-52. 2006..To evaluate the oncological efficacy of reducing cisplatin-based chemotherapy to two cycles in patients with low-volume retroperitoneal stage II nonseminomatous germ cell tumours (NSGCTs)... - The expression of transcription factor activating transcription factor 3 in the human prostate and its regulation by androgen in prostate cancerAlexandre E Pelzer
Department of Urology, Innsbruck Medical University, Innsbruck, Austria
J Urol 175:1517-22. 2006..We found that ATF3 was differently expressed in an in vitro prostate cancer tumor progression model and we investigated the possible role of ATF3 in prostate cancer... - Detection rates and biologic significance of prostate cancer with PSA less than 4.0 ng/mL: observation and clinical implications from Tyrol screening projectAlexandre E Pelzer
Department of Urology, Innsbruck Medical University, Innsbruck, Austria
Urology 66:1029-33. 2005..0 to 3.9 ng/mL and 4.0 to 10 ng/mL (free PSA 18% or less), in a population-based screening project. With the use of prostate-specific antigen (PSA) screening, more PCa is being diagnosed at PSA values of less than 4 ng/mL... - The effect of percentage free prostate-specific antigen (PSA) level on the prostate cancer detection rate in a screening population with low PSA levelsAlexandre E Pelzer
Department of Urology, University of Innsbruck, Anichstrasse 35, A 6020 Innsbruck, Austria
BJU Int 96:995-8. 2005..To evaluate the prostate cancer detection rate at low total prostate-specific antigen (tPSA) ranges of 2.6-4 and 4.1-10 ng/mL, according to different percentage free (f/t) PSA levels in a screening population... - Are transition zone biopsies still necessary to improve prostate cancer detection? Results from the tyrol screening projectAlexandre E Pelzer
Department of Urology, Innsbruck Medical University, Austria
Eur Urol 48:916-21; discussion 921. 2005.... - Prostate cancer detection in men with prostate specific antigen 4 to 10 ng/ml using a combined approach of contrast enhanced color Doppler targeted and systematic biopsyAlexandre Pelzer
Departments of Urology, Innsbruck Medical University, Innsbruck, Austria
J Urol 173:1926-9. 2005..We evaluated the impact of a combined approach of contrast enhanced, color Doppler targeted biopsy (CECD) and systematic biopsy (SB) for the PC detection rate in men with prostate specific antigen (PSA) 4.0 to 10 ng/ml... - Long-term results of laparoscopic retroperitoneal lymph node dissection: a single-center 10-year experienceHannes Steiner
Department of Urology, University of Innsbruck, Innsbruck, Austria
Urology 63:550-5. 2004..Therefore, L-RPLND for Stage I and low-volume retroperitoneal Stage II disease can be performed at centers with experience in urologic laparoscopy and oncology... - Frozen section analysis-guided organ-sparing approach in testicular tumors: technique, feasibility, and long-term resultsHannes Steiner
Department of Urology, University of Innsbruck, Innsbruck, Austria
Urology 62:508-13. 2003.... - Androgen receptor regulation by physiological concentrations of the isoflavonoid genistein in androgen-dependent LNCaP cells is mediated by estrogen receptor betaJasmin Bektic
Department of Urology, University of Innsbruck, Anichstrasse 35, A-6020 Innsbruck, Austria
Eur Urol 45:245-51; discussion 251. 2004..This likely results in a modified response to hormonal stimuli and may help to explain the low incidence of prostate cancer in the Asian population... - Impact of age on complexed PSA levels in men with total PSA levels of up to 20 ng/mLAndreas P Berger
Department of Urology, University of Innsbruck, Innsbruck, Austria
Urology 62:840-4. 2003..Lower cutoff values may help improve the detection of prostate cancer among otherwise healthy men... - Structural changes of the intravesical ureter in children with vesicoureteral reflux-does ischemia have a role?C Schwentner
Department of Pediatric Urology, Institute of Biostatistics, Medical University, Innsbruck, Austria
J Urol 176:2212-8. 2006..These ongoing functional and structural alterations may further deteriorate the active valve mechanism of the ureterovesical junction, causing vesicoureteral reflux... - An autocrine loop for vascular endothelial growth factor is established in prostate cancer cells generated after prolonged treatment with interleukin 6Hannes Steiner
Department of Urology, University of Innsbruck, Anichstrasse 35, A-6020 Innsbruck, Austria
Eur J Cancer 40:1066-72. 2004..Because of the upregulation of IL-6 in patients with prostate cancer, these findings might be clinically relevant... - Large-scale study of clinical impact of PSA velocity: long-term PSA kinetics as method of differentiating men with from those without prostate cancerAndreas P Berger
Department of Urology, Medical University of Innsbruck, Innsbruck, Austria
Urology 69:134-8. 2007..To assess the longitudinal prostate-specific antigen (PSA) changes in a screening population with or without prostate cancer during a 10-year period... - Periprostatic administration of local anesthesia during transrectal ultrasound-guided biopsy of the prostate: a randomized, double-blind, placebo-controlled studyAndreas P Berger
Department of Urology, University of Innsbruck, Innsbruck, Austria
Urology 61:585-8. 2003..We recommend this procedure in men undergoing transrectal ultrasound-guided prostate biopsy... - Regulation of growth of prostate cancer cells selected in the presence of interleukin-6 by the anti-interleukin-6 antibody CNTO 328Hannes Steiner
Department of Urology, Innsbruck Medical University, Innsbruck, Austria
Prostate 66:1744-52. 2006..CONCLUSION: CNTO 328 has a potential in prostate cancer therapy and could be further tested in various combination experimental treatments... - Long-term experience with carboplatin monotherapy for clinical stage I seminoma: a retrospective single-center studyHannes Steiner
Department of Urology, University of Innsbruck, Innsbruck, Austria
Urology 60:324-8. 2002..2%) had WHO grade 1, 5 (4.6%) had grade 2, 2 (1.9%) had grade 3, and 3 (2.8%) had grade 4. CONCLUSIONS: From an oncologic standpoint, two cycles of carboplatin monotherapy was highly effective and very well tolerated by all patients... - Accelerated in vivo growth of prostate tumors that up-regulate interleukin-6 is associated with reduced retinoblastoma protein expression and activation of the mitogen-activated protein kinase pathwayHannes Steiner
Departments of Urology, Pathology, and Medical Chemistry and Biochemistry, University of Innsbruck, Innsbruck, Austria
Am J Pathol 162:655-63. 2003..These findings could be relevant to understand the role of IL-6 in prostate cancer progression... - Molecular effects of the isoflavonoid genistein in prostate cancerJasmin Bektic
Department of Urology, Innsbruck Medical University, Austria
Clin Prostate Cancer 4:124-9. 2005..Herein, we review the current literature on the molecular mechanisms of genistein in relation to its effects on prostate cancer cells... - Occurrence of polyorchidism in a young manAndreas P Berger
Department of Urology, University of Innsbruck, Innsbruck, Austria
Urology 60:911. 2002..However, if a neoplasm is ruled out by ultrasonography, surgical exploration is not needed. We report a case of multiple testicular glands... - Late penile metastasis from primary bladder carcinomaAndreas P Berger
Department of Urology, University of Innsbruck, Innsbruck, Austria
Urology 62:145. 2003..5 years later. No further urothelial carcinoma recurrence was observed during follow-up until the patient died of lung cancer 6 years after the occurrence of penile metastasis. The case is discussed with reference to published reports... - Primary rhabdomyosarcoma of the seminal vesicleAndreas P Berger
Department of Urology, University of Innsbruck, Innsbruck, Austria
J Urol 168:643. 2002 - Photodynamic therapy with intravesical instillation of 5-aminolevulinic acid for patients with recurrent superficial bladder cancer: a single-center studyAndreas P Berger
Department of Urology, University of Innsbruck, Innsbruck, Austria
Urology 61:338-41. 2003..Because of the favorable side-effect profile, PDT can also be applied to patients with comorbidity precluding surgical treatment. Furthermore, PDT represents a second-line treatment for patients with tumor recurrence after BCG failure...